KIMS Q1 Profit Falls 47% Despite 35% Revenue Growth

Krishna Institute of Medical Sciences (KIMS) reported a 47.2% year-on-year decline in consolidated net profit for the first quarter ended June 30, despite strong revenue growth. The hospital chain's net profit fell to Rs 41.5 crore in Q1 FY27, down from Rs 78.6 crore in the corresponding period of the previous financial year.

The decline in profit was attributed to a narrowing of the EBITDA margin, which fell to 18.9% from 22.1% in the year-ago period. However, revenue from operations climbed 35.3% to Rs 1,179.5 crore during the quarter, driven by higher outpatient and inpatient volumes as well as expansion of its hospital network.

KIMS' operating profit also improved, with EBITDA rising 16% year-on-year to Rs 223.4 crore. The company continued to expand its healthcare footprint during the quarter, with its total bed capacity increasing to 7,459 as of June 30, 2026.

Chairman and Managing Director B. Bhaskara Rao stated that the company began FY27 on a strong note with the launch of a new hospital in Palakkad, Kerala. He added that the company's newer hospitals have continued to perform well, with some facilities successfully carrying out complex procedures, including lung transplants.

The steady increase in outpatient and inpatient visits across its hospitals also contributed to the strong growth in revenue during the quarter. On the capital allocation front, KIMS said it has utilised a part of the Rs 1,500 crore raised through a qualified institutional placement (QIP) completed in FY26.

The remaining proceeds have been temporarily invested in mutual funds and parked in a monitoring account. Shares of Krishna Institute of Medical Sciences closed 2.65% higher at Rs 826 on the NSE on Monday, ahead of the announcement of its June quarter results.

KIMS' expansion plans and increasing patient volumes are expected to drive growth in the coming quarters. The company's ability to maintain profitability will be crucial in the face of rising costs and intense competition in the healthcare sector.

In the context of the Indian healthcare industry, KIMS' performance is significant as it highlights the challenges faced by hospital chains in maintaining profitability despite strong revenue growth. The company's focus on expansion and increasing patient volumes is expected to drive growth in the coming quarters.

The Indian healthcare industry is expected to continue growing, driven by increasing demand for healthcare services and government initiatives to improve healthcare infrastructure. KIMS' performance is a reflection of the trends in the industry, and its ability to adapt to changing market conditions will be crucial in the coming quarters.

In conclusion, KIMS' Q1 results highlight the challenges faced by hospital chains in maintaining profitability despite strong revenue growth. The company's focus on expansion and increasing patient volumes is expected to drive growth in the coming quarters, and its ability to maintain profitability will be crucial in the face of rising costs and intense competition in the healthcare sector.